Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI7510 for Prevention of RSV-associated Respiratory Illness in Older Adults
2015-002758-11Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing MEDI7510 with Placebo (2 arms). Primary endpoint: Incidence of first ARA-RI episode. Started Aug 2015; status: terminated.
02
Drugs
MEDI7510
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2015-002758-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002758-11.